DE69120192D1 - Verfahren zur Herstellung von sekretorischen Immunoglobulin-A-Präparaten - Google Patents

Verfahren zur Herstellung von sekretorischen Immunoglobulin-A-Präparaten

Info

Publication number
DE69120192D1
DE69120192D1 DE69120192T DE69120192T DE69120192D1 DE 69120192 D1 DE69120192 D1 DE 69120192D1 DE 69120192 T DE69120192 T DE 69120192T DE 69120192 T DE69120192 T DE 69120192T DE 69120192 D1 DE69120192 D1 DE 69120192D1
Authority
DE
Germany
Prior art keywords
preparations
preparation
secretory immunoglobulin
secretory
immunoglobulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69120192T
Other languages
English (en)
Other versions
DE69120192T2 (de
Inventor
Yoshikazu Yuki
Motoko Baba
Mitsuo Shimizu
Kazuo Kato
Hajime Hiratani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NIHON CHEMICAL RESEARCH K K JA
Original Assignee
NIHON CHEMICAL RESEARCH K K JA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NIHON CHEMICAL RESEARCH K K JA filed Critical NIHON CHEMICAL RESEARCH K K JA
Publication of DE69120192D1 publication Critical patent/DE69120192D1/de
Application granted granted Critical
Publication of DE69120192T2 publication Critical patent/DE69120192T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/04—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0023—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/861—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgG3, IgG4, IgA, or IgY

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69120192T 1990-10-05 1991-10-03 Verfahren zur Herstellung von sekretorischen Immunoglobulin-A-Präparaten Expired - Fee Related DE69120192T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP26920090A JP3145696B2 (ja) 1990-10-05 1990-10-05 分泌型免疫グロブリンａ製剤の製造法

Publications (2)

Publication Number Publication Date
DE69120192D1 true DE69120192D1 (de) 1996-07-18
DE69120192T2 DE69120192T2 (de) 1996-10-10

Family

ID=17469069

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69120192T Expired - Fee Related DE69120192T2 (de) 1990-10-05 1991-10-03 Verfahren zur Herstellung von sekretorischen Immunoglobulin-A-Präparaten

Country Status (6)

Country Link
US (1) US5371196A (de)
EP (1) EP0479597B1 (de)
JP (1) JP3145696B2 (de)
CA (1) CA2052809A1 (de)
DE (1) DE69120192T2 (de)
ES (1) ES2090255T3 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3220539B2 (ja) * 1992-12-25 2001-10-22 日本ケミカルリサーチ株式会社 活性乳蛋白成分含有製品およびその製造法
JPH08506498A (ja) * 1993-02-09 1996-07-16 オクタファルマ・アクチエンゲセルシャフト 非脂質被覆ウイルスの失活方法
HRP940645A2 (en) * 1993-10-06 1996-12-31 Immuno Ag Process for virus deactivation in the presence of polyalkylene glycol and the pharmaceutical preparation thus obtained
DE4434538C2 (de) * 1993-10-06 2000-08-10 Immuno Ag Verfahren zur Virusinaktivierung in Gegenwart eines Polyethers und eines chaotropen Agens
FI94993C (fi) * 1993-11-30 1995-11-27 Nokia Telecommunciations Oy Menetelmä radioyksikön ohjaamiseksi
WO1995022350A1 (en) * 1994-02-18 1995-08-24 Immuno Aktiengesellschaft Composition and method for preventing and treating inflammation with immunoglobulin a
DE4424935C1 (de) * 1994-07-14 1996-03-21 Immuno Ag Humanes virussicheres monomeres Immunglobulin A und Verfahren zu seiner Herstellung
US6034073A (en) * 1995-04-24 2000-03-07 Novavax, Inc. Solvent detergent emulsions having antiviral activity
FI955389A0 (fi) * 1995-11-09 1995-11-09 Antti Sakari Aaltonen Tandskyddande profylaktisk preparat och administreringsmedlen emot mellanoerpatogener
WO1998017786A1 (en) * 1996-10-23 1998-04-30 Oravax, Inc. Heat inactivation of viruses in antibody preparations
TW541179B (en) * 1997-03-19 2003-07-11 Green Cross Corp Process for preparing immunoglobulin preparation
AT405608B (de) * 1997-04-08 1999-10-25 Immuno Ag Verfahren zur inaktivierung von pathogenen, insbesondere von viren, in einem biologischen material
CA2285935C (en) 1997-04-08 2011-01-18 Baxter Aktiengesellschaft An immunotolerant prothrombin complex preparation
UA64742C2 (uk) * 1997-12-24 2004-03-15 Альфа Терапевтик Корпорейшн СПОСІБ ОДЕРЖАННЯ РОЗЧИНУ <font face="Symbol">g</font>-ГЛОБУЛІНУ, ПРИЗНАЧЕНОГО ДЛЯ ВНУТРІШНЬОВЕННОГО ВВЕДЕННЯ, І ПРОДУКТ, ЩО ОДЕРЖУЄТЬСЯ У ЦЕЙ СПОСІБ (ВАРІАНТИ)
US6162904A (en) * 1997-12-24 2000-12-19 Alpha Therapeutic Corporation Manufacturing method for intraveneously administrable immune globulin and resultant product
US6441144B1 (en) 1999-05-20 2002-08-27 Alpha Therapeutic Corporation Method for repairing dual virally inactivated immune globulin for intravenous administration
BR0011648A (pt) * 1999-06-15 2002-03-19 Alpha Therapeutic Corp Método de fabricação de imunoglobulina intravenosa e produto resultante
AU2003211991B2 (en) 2002-02-14 2008-08-21 Chugai Seiyaku Kabushiki Kaisha Antibody-containing solution formulations
KR101645957B1 (ko) * 2008-05-15 2016-08-05 더블유. 헬스 엘.피. 분비 면역글로블린이 풍부한 우유 분획 제조방법
WO2013174971A1 (en) 2012-05-25 2013-11-28 Gottfried Himmler Secretory immunoglobulin deficiency treatment and prophlaxis
US9458230B2 (en) 2013-01-04 2016-10-04 Wisconsin Alumni Research Foundation Secretory IGA compositions, methods of making and methods of use thereof
US9468674B2 (en) 2013-09-24 2016-10-18 Wisconsin Alumni Research Foundation Methods of use of secretory IgA

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL286954A (de) * 1962-01-03
US3763135A (en) * 1971-11-08 1973-10-02 Baxter Laboratories Inc Gamma globulin production from cohn fraction iii using polyethylene glycol
US4124576A (en) * 1976-12-03 1978-11-07 Coval M L Method of producing intravenously injectable gamma globulin
US4439421A (en) * 1982-08-30 1984-03-27 Baxter Travenol Laboratories, Inc. Stabilized gamma globulin concentrate
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
JPH0669961B2 (ja) * 1984-09-25 1994-09-07 株式会社ミドリ十字 免疫グロブリンの加熱処理方法
JPH0825902B2 (ja) * 1985-02-21 1996-03-13 株式会社ミドリ十字 γ−グロブリンの加熱処理方法
EP0225581A3 (de) * 1985-11-30 1989-05-24 Green Cross Corporation Verfahren zur Hitzebehandlung von Immunoglobulinen und Immunoglobulinprodukt
DE69011136T3 (de) * 1989-01-13 2003-10-23 Mitsubishi Pharma Corp Verfahren zur Herstellung einer Protein enthaltenden Zusammensetzung.

Also Published As

Publication number Publication date
JP3145696B2 (ja) 2001-03-12
EP0479597B1 (de) 1996-06-12
JPH04145031A (ja) 1992-05-19
CA2052809A1 (en) 1992-04-06
EP0479597A3 (en) 1993-02-24
US5371196A (en) 1994-12-06
ES2090255T3 (es) 1996-10-16
EP0479597A2 (de) 1992-04-08
DE69120192T2 (de) 1996-10-10

Similar Documents

Publication Publication Date Title
DE69120192D1 (de) Verfahren zur Herstellung von sekretorischen Immunoglobulin-A-Präparaten
DE69321878D1 (de) Verfahren zur Herstellung von tertiären Alkylethern
DE69025905D1 (de) Verfahren zur Herstellung von Copolyestercarbonaten
DE69123662D1 (de) Verfahren zur Herstellung von y-Methacryloxypropylsilanverbindungen
DE69132413D1 (de) Verfahren zur Herstellung von Emulsionen
DE59204836D1 (de) Verfahren zur Herstellung von Polyisocyanaten
DE69214746D1 (de) Verfahren zur Herstellung von primären Aminoorganosilanen
DE59309939D1 (de) Verfahren zur Herstellung von Arenbisphosphinoxide
DE69131264D1 (de) Verfahren zur Herstellung von Silazykloalkanen
DE59303220D1 (de) Verfahren zur Herstellung von 1-Fluorcyclopropyl-methyl-keton
DE59303813D1 (de) Verfahren zur Herstellung von Germaniumdihalogenid-Ether-Addukten
DE69126850D1 (de) Verfahren zur Herstellung von Bistrimellitinimiden
DE59107830D1 (de) Kontinuierliches Verfahren zur Herstellung von 1-Halogen-1-oxophospholenen
DE59205077D1 (de) Verfahren zur Herstellung von Chlorfluornitrobenzolen
DE69314899D1 (de) Verfahren zur Herstellung von Polyaminoborazinen
DE59303720D1 (de) Verfahren zur Herstellung von beta-Naphthylbenzylether
DE69119692D1 (de) Verfahren zur Herstellung von Streptovaricin
DE69315297D1 (de) Verfahren zur Herstellung von Omega-Alkenylchlorsilanen
DE59205092D1 (de) Verfahren zur Herstellung von 2-Nitro-5-fluor- bzw. -5-chlor-phenol
DE69303057D1 (de) Verfahren zur Herstellung von 3-Cyano-6-hydroxypyridin
DE69315317D1 (de) Verfahren zur Herstellung von beta-Cyanoalkylsilanen
DE69325079D1 (de) Verfahren zur Herstellung von Triorganochlorsilane
DE59205946D1 (de) Verfahren zur Herstellung von 2-Aminomethylpiperidin
DE59206271D1 (de) Verfahren zur Herstellung von 2-Chlorpyridinen
DE69318765D1 (de) Verfahren zur Herstellung von Hydridoorganooxysilanen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee